Pharmacogenetic aspects of coumarinic oral anticoagulant therapies.
about
Impact of polymorphisms of the GGCX gene on maintenance warfarin dose in Chinese populations: Systematic review and meta-analysisAssociation of functional VKORC1 promoter polymorphism with occurrence and clinical aspects of ischemic stroke in a Greek population.Spontaneous intra-abdominal bleed following oral anticoagulant therapy.CYP2C9*3 polymorphism presenting as lethal subdural hematoma with low-dose warfarin.The Role of Clinical Variables and VKORC1 Polymorphism in Efficacy and Stability of Acenocoumarol in Neurological Patients.
P2860
Pharmacogenetic aspects of coumarinic oral anticoagulant therapies.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Pharmacogenetic aspects of coumarinic oral anticoagulant therapies.
@en
type
label
Pharmacogenetic aspects of coumarinic oral anticoagulant therapies.
@en
prefLabel
Pharmacogenetic aspects of coumarinic oral anticoagulant therapies.
@en
P2093
P2860
P1476
Pharmacogenetic aspects of coumarinic oral anticoagulant therapies.
@en
P2093
Saurabh Singh Rathore
Shantanu Pande
Surendra Kumar Agarwal
Sushil Kumar Singh
Tulika Mittal
P2860
P2888
P304
P356
10.1007/S12291-011-0133-3
P577
2011-05-01T00:00:00Z
P5875
P6179
1022566148